Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial) | MicrobiomeTrials← Back to trialsNCT07582458
Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2026-06-01Est. Completion: 2027-02-01
Enrollment target: 60 participants Other microbiome trials you might be interested in
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)Crohn Disease (CD)Ulcerative Colitis (UC)ARFIDEating Disorders
Inflammatory bowel diseases (IBD) may influence eating habits and lead some patients to adopt restrictive dietary behavi…
Naples, ItalyCompleted Apr 1, 2025
Crohn Disease (CD)Ulcerative Colitis (UC)IBD (Inflammatory Bowel Disease)
The goal of this clinical trial is to increase the knowledge on what type of diet affects inflammation and how to better…
Malmö, SwedenCompleted Dec 30, 2027